India has witnessed a significant growth in pharmaceutical generic brands with sales over ₹100 crore in the last 15 years. These brands now make up 44% of the domestic formulation market valued at around ₹2 lakh crore. A report by investment banking firm Avendus Capital highlights the exponential increase in brands with sales exceeding ₹100 crore, reaching 388 in FY24 from 21 in FY09. These brands, including some with sales above ₹500 crore, have outpaced the industry growth rate, attributed to factors like lifestyle diseases and quality issues driving reliance on trusted brands.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.